Thursday, December 5, 2019
News on Pathogens and Preparedness
Global Biodefense
No Result
View All Result
  • Featured
  • Pathogens

    Tracing the Ancestral Genome of The Plague

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    Bacillus anthracis concept drawing

    Decontamination of Bacillus Spores from Drinking Water Infrastructure

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    red agar plate with cultured bacteria

    Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

    Turns Out, Bat Influenza Can Give You the Flu

    Turns Out, Bat Influenza Can Give You the Flu

    Crimean-Congo Hemorrhagic Fever

    Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

    Yersinia pestis

    Researchers Optimize Novel Hexaplex PCR Assay for Simultaneous Detection of Anthrax and Plague Pathogens

  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe
  • Featured
  • Pathogens

    Tracing the Ancestral Genome of The Plague

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    African Swine Fever: An Unexpected Threat to the Global Supply of Heparin

    Bacillus anthracis concept drawing

    Decontamination of Bacillus Spores from Drinking Water Infrastructure

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare

    red agar plate with cultured bacteria

    Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

    Turns Out, Bat Influenza Can Give You the Flu

    Turns Out, Bat Influenza Can Give You the Flu

    Crimean-Congo Hemorrhagic Fever

    Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

    Yersinia pestis

    Researchers Optimize Novel Hexaplex PCR Assay for Simultaneous Detection of Anthrax and Plague Pathogens

  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Modeling the Complexities of the Gut for Biodefense Applications

by Global Biodefense
16 Jul 2019
Modeling the Complexities of the Gut for Biodefense Applications
118.4k
VIEWS

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML), with research funding assistance from the Defense Threat Reduction Agency (DTRA), has developed a high-resolution model of the gut immune system to help solve emerging and re-emerging infectious diseases and biodefense challenges.

The advanced model predicts new emerging behaviors and responses to biological threats. The gut ecosystem includes trillions of interactions between host epithelial and immune cells, molecules (cytokines, chemokines and metabolites) and microbes is a massively and dynamically interacting network, like a multidimensional jigsaw puzzle with pieces that are constantly changing shape. These interactions with cooperativity and feedback lead to nonlinear dynamics and unforeseen emergent behaviors across spatiotemporal scales.

The NIMML agent-based modeling (ABM) of the gut uses an array of HPC-driven advanced computational technologies such as the ENteric Immunity SImulator (ENISI) – multiscale modeling (MSM). These models and tools simulate cell phenotype changes, signaling pathways, immune responses, lesion formation, cytokine, chemokine and metabolite diffusions, and cell movements at the gut mucosa.

ENISI MSM is a cutting-edge tool at the forefront of advanced computational modeling and simulation of biological systems. ENISI fully integrates agent-based modeling (ABM) with other computational and mathematical modeling technologies including differential equations-based methods such as ODE and PDE.

NIMML recently published a study in Gigascience where the HPC-driven ENISI MSM multiscale model was used to investigate the underlying immunological mechanisms that promote host tolerance to Helicobacter pylori infection in the gut. H. pylori colonizes the stomach, one of the harshest environments a microbe encounters, of 50% of the human population and persists for prolonged periods of time, often causing a lifelong infection. Although H. pylori causes gastric cancer in 1-2% of cases, it exerts beneficial health effects including protection against allergies and gastroesophageal diseases. The majority of H. pylori colonized individuals, an estimated 85%, do not present any detrimental effects.

“We are pleased to present the first high-resolution, multiscale model of the stomach during infection with H. pylori. This model culminates many years of work at the interface of modeling and immunology experimentation by combining the use of ODE to model intracellular signaling pathways, in combination with PDEs to simulate cytokine, chemokine diffusions and ABM for modeling cell-cell interactions at the cellular and population levels,” said Dr. Hontecillas, the co-Director of NIMML. “The model has been developed, analyzed and calibrated against experimental data with the aim of determining the mechanistic interactions responsible for observed immune profiles.”

Diagram representing the complex interactions of cytokines, microbes, immune cells in the gut
Credit: NIMML

“NIMML’s advanced HPC-driven computational modeling capabilities and artificial intelligence (AI) algorithms in combination with innovative experimental methods have major applications in transforming biodefense. These models are being used in a DTRA-funded project to evaluate several scenarios of possible therapeutic interventions during biological or chemical threats,” said Dr. Josep Bassaganya-Riera, the Director of NIMML. “As a part of a productive NIMML-led collaboration with the Department of Industrial and Systems Engineering at Virginia Tech and Geisinger Healthcare System, we will continue to apply these advanced computational modeling methods for gaining new valuable insights on the mechanisms that delineate functional fates of immune cells and influence disease outcomes during infection.”

Sensitivity analysis methods for the ABMs are still immature. Researchers at NIMML used the outputs for global multi-resolution sensitivity analysis (SA). Building a surrogate model reduced the computational time to run simulations. These new SA methods identified epithelial cells, macrophages and dendritic cells as key factors that delineate the outcome of the infection.

“NIMML’s advanced machine learning based approaches for SA replaced the computational and time-expensive ABM with a surrogate model reducing the computational costs, thereby enabling greater scalability. We used this AI approach to analyze the influential parameters underlying the H. pylori infection,” said Meghna Verma, a NIMML PhD student. “We performed, in silico validation with the results we obtained using our metamodel and discovered that the colonization of H. pylori decreased with a decrease in epithelial cell proliferation and this decrease was mediated by regulatory macrophages and tolerogenic dendritic cells.”

Source: Nutritional Immunology & Molecular Medicine. Edited by Stephanie Lizotte

Tags: Editor Pick
Previous Post

What Happens When a CBRN Agent is Released in an Urban Area? Ask HASP.

Next Post

Ebola Epidemic Officially Declared a Public Health Emergency

Related Posts

Highly Sensitive Epigenomic Technology Combats Disease
Infectious Diseases

Highly Sensitive Epigenomic Technology Combats Disease

4 Dec 2019
Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria
Antimicrobial Resistance

Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria

11 Nov 2019
Pathogens

Tracing the Ancestral Genome of The Plague

8 Nov 2019
Genomic Research Viruses
Industry News

Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral

8 Nov 2019
Early Diagnostic Imaging of Sulfur Mustard Poisoning
CBRNE

Early Diagnostic Imaging of Sulfur Mustard Poisoning

27 Oct 2019
Highly Diluted Dose of Ebola Vaccine Shown Effective in Primate Study
Medical Countermeasures

Highly Diluted Dose of Ebola Vaccine Shown Effective in Primate Study

20 Oct 2019
Load More
Next Post
A man in a neon yellow safety vests checks temperatures wit a contactless laser thermometer. People in Goma wait in line for their turn

Ebola Epidemic Officially Declared a Public Health Emergency

Headlines

  • African Swine Fever Kills More Than 20 Wild Boar in Poland
  • Samoa Measles Outbreak: Death Toll Rises To 53, Mostly Children
  • OPCW Defends Syria Attack Conclusions After Document Leaks
  • Osama bin Laden’s “Anthrax Scientist” Freed by Malaysia
  • New Mobile Lab Born Out of Scientists’ Frustration During Ebola Outbreak

Recommended

  • Highly Sensitive Epigenomic Technology Combats Disease
  • Interview: Ambassador Bonnie Jenkins on 8 years of Combating WMD Terrorism
  • There’s No Such Thing as Just-in-Time Healthcare and Public Health Preparedness
  • Threat Detection in Your Pocket
  • Inflammatix Wins BARDA Backing for Diagnostic to Rapidly Distinguish Bacterial from Viral Infections

Featured Partner

  • About
  • Contact
  • Privacy
  • Subscribe

© 2019 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • Pathogens
  • Directory
  • Job Board
  • Funding
    • Contracts + Grants
    • Funding Awards
    • Requests for Information
    • Industry News
  • Events
    • All Events
    • Conferences + Meetings
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Headlines
  • Subscribe

© 2019 Stemar Media Group LLC